Effects of immunosuppressive drugs on serum lipid levels in renal transplant recipients

Transplantation Proceedings

Volumn 38, Issue 2, 2006, Pages 502-505

  Kanbay, M ^a,b   Yildirir, A ^a   Akcay, A ^a   Colak, T ^a   Ozdemir, F N ^a   Muderrisoglu, H ^a   Haberal, M ^a  

^a BASKENT UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOSUPPRESSIVE AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TRIACYLGLYCEROL; TSUKUBAENOLIDE;

ADOLESCENT; ADULT; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HUMAN; KIDNEY DISEASE; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; ANTILIPEMIC AGENTS; CHILD; FEMALE; HUMANS; HYPERLIPIDEMIAS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIPIDS; MALE; MIDDLE AGED;

EID: 33645063743     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.12.052     Document Type: Conference Paper

References (27)

1. H. Maeda, K. Sakamato, H. Kashiwabara Effect of hypertension, hyperlipidemia and cyclosporine A therapy on long-term renal allograft survival Transplant Proc 28 1996 1633
2. A.E. Bittar, P.J. Ratcliffe, A.J. Richardson The prevalence of hyperlipidemia in renal transplant recipients Transplantation 50 1990 987
3. J.I. Roodnat, P.G. Mulder, R. Zietse Cholesterol as an independent predictor of outcome after renal transplantation Transplantation 69 2000 1704
4. A. Asberg, A. Hartmann, E. Fjeldsa Atorvastatin improves endothelial function in renal transplant recipients Nephrol Dial Transplant 16 2001 1920
5. A. Lindholm, D. Albrechtsen, L. Frodin Ischemic heart disease major cause of death and graft loss after renal transplantation in Scandinavia Transplantation 60 1995 451
6. B.L. Kasiske, C. Guijarro, Z.A. Massy Cardiovascular disease after renal transplantation J Am Soc Nephrol 7 1996 158
7. B.L. Kasiske, A.J. Umen Persistent hyperlipidemia in renal transplant patients Medicine 66 1987 309
8. A.E. Bittar, P.J. Ratcliffe, A.J. Richardson The prevalence of hyperlipidemia in renal transplant recipients Transplantation 50 1990 987
9. D.C. Catran, G. Steiner, D.R. Wilson Hyperlipidemia after renal transplantation natural history and pathophysiology Ann Intern Med 91 1979 554
10. B.L. Kasiske Hyperlipidemia in patients with chronic renal disease Am J Kidney Dis 32 1998 142
11. E. Dimeny, B. Fellstrom, E. Larsson Chronic vascular rejection and hyperlipoproteinemia in renal transplant patients Clin Transplant 7 1993 482
12. Z.A. Massy, C. Guijarro, M.R. Weiderkehr Chronic renal allograft rejection immunologic and nonimmunologic risk factors Kidney Int 49 1996 518
13. M.S. Marketl, N. Sumrani, A. Dibenedetto Effect of early hyperlipidemia on graft and patient survival in cyclosporine-treated renal transplant patients Am J Kidney Dis 22 1993 233
14. T. Colak, H. Karakayali, M.C. Yagmurdur Effect of conversion from cyclosporine to tacrolimus on lipid profiles in renal transplant recipients Transplant Proc 34 2002 2081
15. A.S. Wierzbickii The role of lipid lowering in transplantation Int J Clin Pract 65 1999 33
16. A. Stephan, A. Barbari, H. Karam Hyperlipidemia and graft loss Transplant Proc 34 2002 2423
17. J.D. Pirsch, J. Miller, M.H. Deirhoi A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation Transplantation 63 1997 977
18. R. Sattrthwaite, S. Aswad, V. Sunga Incidence of new-onset hypercholesterolemia in renal transplant patients treated with FK506 or cyclosporine Transplantation 65 1998 445
19. K.-C. Tse, M.-F. Lam, P.-S. Yip A log-term study on hyperlipidemia in stable renal transplant recipients Clin Transplant 18 2004 274
20. D.E. Hricik, J.T. Mayes, J.A. Schulak Independent effects of cyclosporine and prednisone on posttransplant hypercholesterolemia Am J Kidney Dis 18 1991 353
21. A.M. Castelao, J.M. Grino, E. Andres HMG-CoA reductase inhibitor lovastatin and simvastatin in the treatment of hypercholesterolemia after renal transplantation Transplant Proc 25 1993 1043
22. M.A. Rehman, M.H. Al-Sulaiman, D.H. Mousa Effects of simvastatin in hyperlipidemic renal transplant patients receiving cyclosporine Transplantation 60 1995 397
23. J.L. Austen, F.A. Shifrin, M.R. Bartucci Effects of fluvastatin on hyperlipidemia after renal transplantation influence of steroid therapy Ann Pharmacother 30 1996 1386
24. M. Aviram Interaction of oxidized low-density lipoprotein with macrophages in atherosclerosis and the antiatherogenicity of antioxidants Eur J Clin Biochem 34 1996 599
25. M.L. Alvarez, P. Errasti, G. Gomez Effect of atorvastatin on the treatment of hypercholesterolemia after renal transplantation Transplant Proc 31 1999 2328
26. J. Gumprecht, M. Zychma, W. Grzeszczak Simvastatin induced rhabdomyolysis in a CsA-treated renal transplant recipient Med Sci Monit 9 2003 CS89
27. C.L. Corpier, P.H. Jones, W.N. Suki Rhabdomyolysis and renal injury with lovastatin use JAMA 260 1988 239